Zosano Pharma Corporation reported impairment charges for the first quarter ended March 31, 2022. For the quarter, the company reported impairment loss of $25.9 million for the three months ended March 31, 2022, consists of the write-down of $24.8 million of property and equipment and $1.1 million of right-of-use assets.